ID: ALA4243886

Max Phase: Preclinical

Molecular Formula: C12H8O4S

Molecular Weight: 248.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=Cc1ccc(-c2ccc(O)c(C(=O)O)c2)s1

Standard InChI:  InChI=1S/C12H8O4S/c13-6-8-2-4-11(17-8)7-1-3-10(14)9(5-7)12(15)16/h1-6,14H,(H,15,16)

Standard InChI Key:  QCDKZHIGSPUDSP-UHFFFAOYSA-N

Associated Targets(non-human)

Hydroxyacid oxidase 1 172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.26Molecular Weight (Monoisotopic): 248.0143AlogP: 2.63#Rotatable Bonds: 3
Polar Surface Area: 74.60Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.68CX Basic pKa: CX LogP: 3.25CX LogD: -0.26
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.82Np Likeness Score: -0.47

References

1. Moya-Garzón MD, Martín Higueras C, Peñalver P, Romera M, Fernandes MX, Franco-Montalbán F, Gómez-Vidal JA, Salido E, Díaz-Gavilán M..  (2018)  Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.,  61  (16): [PMID:30028141] [10.1021/acs.jmedchem.8b00399]

Source